People with diabetes who access an online self-management portal through mobile devices have better medication adherence and glycemic control than those with computer-only or no access to the portal, researchers report.
Adherence to first-line diabetes medication, ascertained from prescription records, is the only routine clinical variable that is a strong indicator of people’s adherence to second-line treatment, say researchers.
Targeting specific populations of individuals with type 2 diabetes for intensive interventions to optimize their insulin use may result in better glycemic control than an untargeted approach, findings from the TARGIT-Diabetes trial suggest.
Patients who are not diligent about taking their antidiabetic medications during the first year after type 2 diabetes diagnosis are at increased risk for cardiovascular events and death over the subsequent years, research shows.
Adherence to lipid-lowering drugs is crucial for reducing cardiovascular disease risk among patients with type 2 diabetes, but taking only some of the prescribed medication is better than none at all, study results suggest.